Spotlight Innovation Logo Image

Spotlight Innovation

Spotlight Innovation Banner Image

Spotlight Innovation has reached its limit for report views.

Please check back to see if Spotlight Innovation has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2016 Annual Report and Form 10K

Spotlight Innovation

Archived Annual Reports

  • Spotlight Innovation
  • Spotlight Innovation
  • Spotlight Innovation

About Spotlight Innovation

1-10 Employees
Based in West Des Moines, Iowa

Spotlight Innovation Inc., formerly American Exploration Corporation, is a bioscience company. The Company is focused on acquiring the rights, through acquisition, license or otherwise, to various technologies. The Company is engaged in identifying and targeting technology candidates, including cancer drugs and treatment therapies for various disease states; drug and related treatment therapies for various infectious diseases, and other technology candidates. The Company focuses on diseases that are rare, which are known as orphan diseases, or new or common but underserved, such as feline chronic kidney disease. As of December 31, 2015, the Company had three subsidiaries: Celtic Biotech Iowa, Inc., CDT Veterinary Therapeutics, Inc. and Memcine Pharmaceuticals, Inc. Through its subsidiary, Celtic Biotech Iowa, Inc., it develops a range of drug candidates, such as Crotoxin, Cardiotoxin, VRCTC310 and Crotamine. Through its subsidiary, Memcine Pharmaceuticals, Inc., it offers Immunoplex.

Ticker:
STLT
Exchange:
OTC (See More OTC Companies)
Industry:
--None-- (See More --None-- Companies)
Sector:
--None-- (See More --None-- Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol